We assumed that the number of CTCs is distributed as a Poisson(m) when m is the average number of CTCs collected in 7.5 ml of blood. A sampling error was considered since 7.5 ml of blood are analysed from a total blood volume of 5 liters. In fact, assuming m=3 and 1 as cut-off, the probability of detecting no CTC was equal to 0.05: 5 % of subjects with 2000 CTC present in their total blood volume would have no CTC detected in 7.5 ml. Analysing 2 samples of 7.5ml would decrease the percentage subjects that are wrongly classified not at risk to 2%. Yi being the number of sampled CTCs in 7.5 ml of blood at the i-th measurement, we assumed it was identically distributed as Poisson(m=3) and P(Yi=0 | number of CTCs >=1)=0.05. Two measurements of CTCs were simulated for 10000 people to study the number of CTCs' change 'by chance'. Namely, both the measurements are generated from the same process in order to assess the behaviour of the biomarker for two successive measurements when no parameter has changed (i.e. no treatment effect). The probability of not having CTCs at the second measurement given that at the first measurement k CTC was detected, Prob(Y2=0|Y1=k) was high for k=1, 2 :
